TEGISON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tegison, and when can generic versions of Tegison launch?
Tegison is a drug marketed by Roche and is included in one NDA.
The generic ingredient in TEGISON is etretinate. Additional details are available on the etretinate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TEGISON?
- What are the global sales for TEGISON?
- What is Average Wholesale Price for TEGISON?
Summary for TEGISON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Patent Applications: | 3,318 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TEGISON at DailyMed |
![TEGISON drug patent expirations Drug patent expirations by year for TEGISON](/p/graph/s/t/TEGISON-patent-expirations.png)
US Patents and Regulatory Information for TEGISON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | TEGISON | etretinate | CAPSULE;ORAL | 019369-001 | Sep 30, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Roche | TEGISON | etretinate | CAPSULE;ORAL | 019369-002 | Sep 30, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TEGISON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche | TEGISON | etretinate | CAPSULE;ORAL | 019369-001 | Sep 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Roche | TEGISON | etretinate | CAPSULE;ORAL | 019369-002 | Sep 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Roche | TEGISON | etretinate | CAPSULE;ORAL | 019369-001 | Sep 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TEGISON
See the table below for patents covering TEGISON around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Bulgaria | 60406 | ⤷ Sign Up | |
European Patent Office | 0002533 | USE OF RETINOIDS AS MEDICINES | ⤷ Sign Up |
Germany | 2862480 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |